NCT06643819RecruitingPhase 3
Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
A Randomized, Double-blind, Active-controlled, Multi-center, Therapeutic Confirmatory, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
Source: ClinicalTrials.gov · Last updated 11 Dec 2025
Brief summary (registry, in English)
Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A(Sacubitril∙Valsartan)
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 324 (estimated)
- First submitted
- 14 Oct 2024
- Start date
- 14 Oct 2024
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Chong Kun Dang Pharmaceutical
- Diseases
- High blood pressure
- NCT number
- NCT06643819
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 324
- From 14 Oct 2024 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants who require combination administration of antihypertensive drugs other than clinical trial drugs during the clinical trial participation period.
- Participants who treated other clinical trial drugs within 4 weeks of screening visit.
- Pregnant women, lactating women, or Subjects who do not agree to use appropriate contraception during the clinical trial period and for two weeks after the end of administration of the last clinical trial drug
Other illness
- Participants with a history of secondary hypertension or suspected secondary hypertension.
- Participants with type 1 diabetes or poorly controlled diabetes.
- Participants with a history of drug or alcohol abuse or suspected patient within 24 weeks as of the time of screening
Other
- Participants with a orthostatic hypotension.
- Participants who are unable to participate in this clinical trial at the discretion of the investigator.
Who the study is looking for
- Participants who are 19 years old or older.
- Participants who have voluntarily decided to participate in this clinical trial and signed ICF.
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wonju Severance Christian Hospital Coordinator of this site? Confirm its status | Wŏnju | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.